NPI Details
BOULDER GX is a clinical medical laboratory in Spring, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. BOULDER GX NPI is 1447911409. The provider is registered as an organization entity type.
The provider Is Doing Business As Total Lab Solutions.
The provider's business location address is:
25003 PITKIN RD STE F300
SPRING, TX
ZIP 77386-523
Phone: (866) 648-1117
The provider's authorized official is Scott Zack .
The authorized official title is Owner and has the following contact phone number (248) 225-8417.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
- Test for detecting genes associated with cancer (HCPCS:81455)
- Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
The enumeration date for this NPI number is 1/3/2022 and was last updated on 3/15/2023.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | | | Yes |
